european medicines agency glp-1 vision loss recommendation november 2025 Eye disorder is a 'very rare' side effect of weight-loss drugs, concludes EMA review Popular weight loss drugs like

Lexarias DehydraTECH-CBD Achieves Superior Human Blood Absorption Levels December 21, 2022 Lexaria has demonstrated superior cannabidiol (CBD) blood absorption levels from its patented DehydraTECH-CBD relative to those of published, pharmaceutical-grade CBD industry comparators

Metalorganic frameworks have also emerged as highly tunable carriers for vaccine antigens

Ong et al., Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021, The Lancet, vol

Randomized trialTirzepatide evidence2022 Tirzepatide Once Weekly for the Treatment of Obesity Primary SURMOUNT-1 trial source for tirzepatide weight-loss ranges and tolerability